Table 4. Stratification analyses for the association of serum RBP4 with the presence of CAD in patients with SCH.

	Categorical				Continuous
	Crude OR (95%CI)	P value	Adjusted OR (95%CI)	P value	Crude OR (95%CI)	P value	Adjusted OR (95%CI)	P value
Diabetes
With diabetes	1.11 (1.03 – 1.17)	<0.001	1.41 1 (0.78 – 2.17)	0.066	1.15 (1.07 – 1.23)	<0.001	1.27 1 (0.99 – 1.61)	0.052
Without diabetes	1.57 (1.39 – 1.86)	<0.001	1.82 1 (1.46 – 2.13)	<0.001	1.15 (1.08 – 1.22)	<0.001	1.17 1 (1.07 – 1.27)	<0.001
Gender
Male	1.16 (1.03 – 1.19)	<0.001	1.61 2 (1.29 – 1.92)	0.004	1.20 (1.09 – 1.31)	<0.001	1.26 2 (1.09 – 1.48)	0.002
Female	1.89 (1.34 – 2.31)	<0.001	1.64 2 (1.17 – 1.85)	<0.001	1.12 (1.06 – 1.17)	<0.001	1.18 2 (1.09 – 1.28)	<0.001

¹ The adjusted model included age, gender, BMI, smoking, hypertension, TSH, T3, TC, TG, LDL-C, HDL-C, FBG, UA, and Cr.

² The adjusted model included age, BMI, smoking, hypertension, diabetes, TSH, T3, TC, TG, LDL-C, HDL-C, FBG, UA, and Cr.

SCH, subclinical hypothyroidism; CAD, coronary artery disease; OR, odds ratio; CI, confidence interval.